RIL
ARCT icon

Rothschild Investment LLC’s Arcturus Therapeutics ARCT Stock Holding History

Rothschild Investment LLC’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.17K Buy
323
+256
+382% +$2.02K ﹤0.01% 2723
2026
Q1 		$517 Buy
+67
New +$489 ﹤0.01% 3115
2025
Q4 		– Sell
-45
Closed -$829 – 3433
2025
Q3 		$829 Hold
45
– – ﹤0.01% 2663
2025
Q2 		$585 Sell
45
-10
-18% -$118 ﹤0.01% 2691
2025
Q1 		$582 Buy
55
+20
+57% +$317 ﹤0.01% 2573
2024
Q4 		$594 Buy
35
+20
+133% +$377 ﹤0.01% 2464
2024
Q3 		$348 Buy
15
+5
+50% +$107 ﹤0.01% 2570
2024
Q2 		$244 Buy
+10
New +$303 ﹤0.01% 2404

Other funds holding ARCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ELI
Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Rothschild Investment LLC's ARCT Position: Q2 2026 in Review

Rothschild Investment LLC increased its Arcturus Therapeutics (ARCT) stake by 382% in Q2 2026, buying an estimated $2.02K and bringing the position to 323 shares worth $2.17K. The position accounts for ﹤0.01% of the portfolio, ranked #2723.

Rothschild Investment LLC first reported a position in ARCT in Q2 2024 and has held it in 8 quarters since. 48 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Rothschild Investment LLC held 323 shares of Arcturus Therapeutics worth $2.17K as of Q2 2026.
  • Rothschild Investment LLC bought 256 Arcturus Therapeutics shares in Q2 2026, an estimated $2.02K.
  • Arcturus Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2723 holding.
  • Rothschild Investment LLC first reported a position in Arcturus Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 48 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.